Cargando…

Dopamine in Autism Spectrum Disorders—Focus on D2/D3 Partial Agonists and Their Possible Use in Treatment

Autism spectrum disorders (ASD) are a group of disorders characterized by impairment in social communication and repetitive and stereotyped behaviors. ASD etiology is very complex, including the effect of both genetic and environmental factors. So far, no specific treatment for the core symptoms of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mandic-Maravic, Vanja, Grujicic, Roberto, Milutinovic, Luka, Munjiza-Jovanovic, Ana, Pejovic-Milovancevic, Milica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850940/ https://www.ncbi.nlm.nih.gov/pubmed/35185637 http://dx.doi.org/10.3389/fpsyt.2021.787097

Ejemplares similares

Autism spectrum disorder and Coffin–Siris syndrome—Case report
por: Milutinovic, Luka, et al.
Publicado: (2023)

Autism Spectrum Disorders and Perinatal Complications—Is Oxidative Stress the Connection?
por: Mandic-Maravic, Vanja, et al.
Publicado: (2019)

Glutathione S-Transferase Polymorphisms and Clinical Characteristics in Autism Spectrum Disorders
por: Mandic-Maravic, Vanja, et al.
Publicado: (2021)

Mental Health, Alcohol and Substance Use of Refugee Youth
por: Vasic, Jelena, et al.
Publicado: (2021)

Positive Effects of the Caregiver Skill Training Program on Children With Developmental Disabilities: Experiences From Serbia
por: Glumbic, Nenad, et al.
Publicado: (2022)

Treatment of Symptom Clusters in Schizophrenia, Bipolar Disorder and Major Depressive Disorder With the Dopamine D3/D2 Preferring Partial Agonist Cariprazine
por: Batinic, Borjanka, et al.
Publicado: (2021)

Sex Differences in Autism Spectrum Disorders: Does Sex Moderate the Pathway from Clinical Symptoms to Adaptive Behavior?
por: Mandic-Maravic, Vanja, et al.
Publicado: (2015)

Editorial: Psychiatric Comorbidities in Children and Adolescents With ASD and in Typically Developing Children
por: Raleva, Marija, et al.
Publicado: (2022)

Mental health and addiction in young refugees-Research on prevalence of alcohol and substance use, PTSD and psychological difficulties experienced by young migrants and refugees placed in two refugee centers in Serbia in the time of COVID-19 pandemic
por: Vasic, J., et al.
Publicado: (2023)

Dopamine Receptor Partial Agonists: Do They Differ in Their Clinical Efficacy?
por: Mohr, Pavel, et al.
Publicado: (2022)

Determinants of quality of life among individuals seeking mental health care after termination of state of emergency due to the coronavirus disease 2019 pandemic
por: Maric, Nadja P., et al.
Publicado: (2021)

Molecular Imaging of Dopamine Partial Agonists in Humans: Implications for Clinical Practice
por: Hart, Xenia M., et al.
Publicado: (2022)

Interaction of glutathione S-transferase polymorphisms and tobacco smoking during pregnancy in susceptibility to autism spectrum disorders
por: Mandic-Maravic, Vanja, et al.
Publicado: (2019)

Case report: Open bite as an extrapyramidal side effect with aripiprazole, a dopamine partial agonist
por: Sumi, Satoko, et al.
Publicado: (2022)

Electroencephalography in Assessment of Autism Spectrum Disorders: A Review
por: Milovanovic, Maja, et al.
Publicado: (2021)

Partial Agonists and Dual Disorders: Focus on Dual Schizophrenia
por: Peris, Lola, et al.
Publicado: (2021)

Editorial: Novel antipsychotics within and beyond clinical trials: The treatment of overlapping psychiatric disorders with D3-D2 partial agonists
por: Németh, György, et al.
Publicado: (2022)

Successful treatment of dopamine dysregulation syndrome with dopamine D(2) partial agonist antipsychotic drug
por: Mizushima, Jin, et al.
Publicado: (2012)

Early Clinical Effects of Novel Partial D3/D2 Agonist Cariprazine in Schizophrenia Patients With Predominantly Negative Symptoms (Open-Label, Non-controlled Study)
por: Ivanov, Stanislav V., et al.
Publicado: (2022)

Editorial: Community series in novel antipsychotics within and beyond clinical trials: symptom-based treatment of psychiatric disorders with D3-D2 partial agonists, volume II
por: Falkai, Peter, et al.
Publicado: (2023)

Preferential Effects of Cariprazine on Counteracting the Disruption of Social Interaction and Decrease in Extracellular Dopamine Levels Induced by the Dopamine D(3) Receptor Agonist, PD-128907 in Rats: Implications for the Treatment of Negative and Depressive Symptoms of Psychiatric Disorders
por: Kehr, Jan, et al.
Publicado: (2022)

Serbian Language version of the Modified Checklist for Autism in Toddlers, Revised, with Follow-Up: Cross-Cultural Adaptation and Assessment of Reliability
por: Carakovac, Mia, et al.
Publicado: (2016)

Human Autoantibodies Against N-Methyl-D-Aspartate Receptor Modestly Alter Dopamine D1 Receptor Surface Dynamics
por: Gréa, Hélène, et al.
Publicado: (2019)

Mental healthcare in Serbia
por: Tosevski, Dusica Lecic, et al.
Publicado: (2010)

Discovery research and development history of the dopamine D(2) receptor partial agonists, aripiprazole and brexpiprazole
por: Kikuchi, Tetsuro, et al.
Publicado: (2021)

Vitamin D Deficiency During Pregnancy and Autism Spectrum Disorders Development
por: Principi, Nicola, et al.
Publicado: (2020)

Striatal increase of dopamine receptor 2 density in idiopathic and syndromic mouse models of autism spectrum disorder
por: Chhabra, Stuti, et al.
Publicado: (2023)

Potential Mechanisms for Why Not All Antipsychotics Are Able to Occupy Dopamine D(3) Receptors in the Brain in vivo
por: Kiss, Béla, et al.
Publicado: (2022)

Autism Spectrum Disorder and Narcolepsy: A Possible Connection That Deserves to Be Investigated
por: Posar, Annio, et al.
Publicado: (2020)

Beneficial Effects of GLP-1 Agonist in a Male With Compulsive Food-Related Behavior Associated With Autism
por: Järvinen, Anna, et al.
Publicado: (2019)

Cariprazine, A Dopamine D(2)/D(3) Receptor Partial Agonist, Modulates ABCG2-Mediated Multidrug Resistance in Cancer
por: Hussein, Noor, et al.
Publicado: (2018)

The Role of the Dopamine D2 Receptor in Form-Deprivation Myopia in Mice: Studies With Full and Partial D2 Receptor Agonists and Knockouts
por: Huang, Furong, et al.
Publicado: (2020)

The novel atypical antipsychotic cariprazine demonstrates dopamine D(2) receptor‐dependent partial agonist actions on rat mesencephalic dopamine neuronal activity
por: Delcourte, Sarah, et al.
Publicado: (2018)

Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose
por: Seeman, P
Publicado: (2016)

Mesolimbic Dopamine Transients in Motivated Behaviors: Focus on Maternal Behavior
por: Robinson, Donita L., et al.
Publicado: (2011)

Enhanced Dopamine D1 and BDNF Signaling in the Adult Dorsal Striatum but not Nucleus Accumbens of Prenatal Cocaine Treated Mice
por: Tropea, Thomas F., et al.
Publicado: (2011)

Vitamin-D Deficiency As a Potential Environmental Risk Factor in Multiple Sclerosis, Schizophrenia, and Autism
por: Kočovská, Eva, et al.
Publicado: (2017)

Vitamin D status in children with a psychiatric diagnosis, autism spectrum disorders, or internalizing disorders
por: Muskens, Jet, et al.
Publicado: (2022)

Mental health law in Serbia – an important step towards destigmatisation
por: Tosevski, Dusica Lecic, et al.
Publicado: (2013)

A Probable Way Vitamin D Affects Autism Spectrum Disorder: The Nitric Oxide Signaling Pathway
por: Wang, Bing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sdpmgo4u8l5pgjc3dt67poimc3